Reader sentiment, not investment advice. One vote per visitor; click again to change it.
UCB is priced at $33.81 right now, down 0.88% on the session. That puts its market value at $4.08B, 2261st largest among the 3132 stocks we cover.
Over a full year the shares have ranged across $27.78 to $36.91, which puts the current price roughly 66% of the way up that band.
Revenue for ANNUAL, ended Dec 2025 was $1.04B, up 11.9% from a year earlier, with $328.10M of net profit (a 34.1% margin).
The stock changes hands at 11.0 times trailing earnings, 15% below its five-year average of 13.0.
3 analysts follow the stock and the average call is "buy". The mean target, $40.33, sits 19.3% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 4 factors below, ranked against the 3132 U.S. stocks BeStock covers.
Cheaper than usual on its own 5-year P/E history scores higher.
Higher trailing yield than most of BeStock’s coverage scores higher.
Trading closer to its 52-week high than most peers scores higher.
3 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
UCB is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2021-01-04, the strategy has returned 389% (231.1% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $40.33, 19.3% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $36.11, so shares trade 6.4% below that estimate. On earnings multiple, it sits in the 30th percentile of its own five-year valuation range (cheaper than usual).
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Quote as of Oct 5, 2026 10:20 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 3,132 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
$33.81 is the latest print for UCB, a move of -0.88% against yesterday's close of $34.11. Today's low and high so far: $33.66 and $34.21.
Equity value comes to $4.08B at the current price. By that measure it is number 2261 of the 3132 names in our coverage.
Buyers pay 11.0 times the last twelve months of profit (EPS $2.62). Averaged over five years the multiple has been 13.0, and today's level ranks in the 30th percentile of its own history.
The year's floor is $27.78 and the ceiling $36.91. Shares are 8.4% away from that ceiling.
It does. Payouts over the past twelve months work out to a 2.96% yield; the latest ex-dividend date was September 15, 2026.
Of 3 analysts, 67% say buy, 33% hold and 0% sell. Price targets average $40.33, with the most cautious at $38.00 and the most optimistic at $42.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on UCB.